Dr Karim Fizazi highlights the news on prostate cancer at the European Multidisciplinary Cancer Conference in Stockholm. The top news highlights how in the past ten years on two major developments have occurred in castration resistant prostate cancer; however, five new drugs, chemotherapies and now the information on alpha particles have been unveiled.